Tracking Cathie Wood: Added over 270,000 shares of CRCL and more than 180,000 shares of SpaceX, while significantly reducing positions in Roblox and the precision medicine sector

On Wednesday (August 5), the three major U.S. stock indices diverged. The S&P 500 dipped slightly by 0.17%, closing at 7,723.55; tech stocks came under notable pressure, with the Nasdaq falling 0.83% to close at 26,363.44; meanwhile, the Dow Jones Industrial Average rose against the trend by 0.49%, ending at 54,349.12—indicating clear signs of capital rotation across sectors.

Amid the Nasdaq pullback, Cathie Wood actively increased exposure to high-growth segments such as crypto financial infrastructure and space technology on the day, while trimming positions in consumer entertainment and certain healthcare holdings.

Symbols

Buying focus: Crypto infrastructure, space technology, and AI computing power

$Circle (CRCL.US)$ CRCL received ARK’s largest buy of the day, with 273,343 shares purchased. As the issuer of USDC—the world’s largest stablecoin—Circle sits at the core of crypto financial infrastructure. Its compliance roadmap and rising institutional adoption rates may underpin ARK’s confidence in its long-term valuation re-rating potential.

$SpaceX (SPCX.US)$ Purchased an additional 181,830 shares, continuing ARK’s deep strategic positioning in the space economy. Advances in Starship’s reusability technology and the expanding global user base of Starlink could further solidify SpaceX’s nearly unassailable competitive moat in satellite internet and space transportation.

$NVIDIA (NVDA.US)$ Bought 80,415 more shares. Against the backdrop of sustained strong demand for AI computing power, NVIDIA’s GPU ecosystem and CUDA platform have built a deep technological moat. ARK’s latest purchase likely reaffirms its long-term investment thesis on AI infrastructure.

$GeneDx Holdings (WGS.US)$ Acquired an additional 57,019 shares. GeneDx specializes in whole-exome and whole-genome sequencing, and its AI-driven rare disease diagnostics platform aligns closely with ARK’s core precision medicine investment theme. ARK likely sees accelerating commercialization potential in GeneDx’s genomics diagnostics business.

$Twist Bioscience (TWST.US)$ Purchased 26,732 more shares. Twist excels in its synthetic DNA manufacturing platform and serves as a key infrastructure provider in the synthetic biology space. ARK’s move likely reflects continued confidence in the long-term value of foundational synthetic biology platforms.

Selling side: Rebalancing positions in consumer entertainment and select healthcare holdings

$Roblox (RBLX.US)$ Experienced the largest reduction, with 467,486 shares sold. The metaverse sector has recently faced slowing user growth and monetization pressures. ARK’s significant position reduction likely reflects a reallocation of capital following revised near-term fundamental expectations.

$AtaiBeckley (ATAI.US)$ Reduced position by 181,001 shares. Although psychedelic therapy holds long-term innovative potential, regulatory approval uncertainty remains a key risk. ARK’s move is likely aimed at lowering concentration risk in this niche segment as part of prudent risk management.

$Shopify (SHOP.US)$ Sold 89,033 shares. As a key e-commerce infrastructure play, Shopify has seen strong recent share price performance. ARK’s sale appears to be a routine rebalancing move, reallocating capital toward names offering greater valuation upside.

$Palantir (PLTR.US)$ Reduced holding by 70,259 shares. Palantir’s stock has traded at elevated levels due to ongoing AI contract wins in both government and enterprise segments. ARK’s partial position adjustment likely reflects a cautious assessment of its current valuation relative to future growth potential.

$Iridium Communications (IRDM.US)$ Reduced holdings by 15,945 shares,$Strata Critical Medical (SRTA.US)$ Reduced holdings by 5,610 shares,$Brera Holdings (SLMT.US)$ Reduced holdings by 4,404 shares,$Deere (DE.US)$ Reduced holdings by 3,211 shares,$Teledyne Technologies (TDY.US)$ Reduced holdings by 2,891 shares,$Roku Inc (ROKU.US)$ Reduced holdings by 100 shares. The above-mentioned reductions are relatively modest in scale, likely reflecting routine portfolio rebalancing or liquidity management activities, with overall impact remaining manageable.

Futubull’s [Opportunities Page] now features celebrity portfolio tracking! Choose from multiple celebrity holdings, follow top investors’ moves with one click, precisely target quality stocks, and invest with greater confidence!

980K Views